Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.

Rubenstein, J L

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. [electronic resource] - Neoplasia (New York, N.Y.) - 306-14 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1522-8002

10.1038/sj.neo.7900102 doi


Animals
Antibodies--therapeutic use
Brain Neoplasms--blood supply
Endothelial Growth Factors--antagonists & inhibitors
Female
Glioblastoma--blood supply
Humans
In Situ Nick-End Labeling
Lymphokines--antagonists & inhibitors
Neovascularization, Pathologic--prevention & control
Rats
Rats, Nude
Survival Rate
Time Factors
Transplantation, Heterologous
Tumor Cells, Cultured
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors